|

Selpercatinib Clinical Trials

3 actively recruiting trials across 1 location

Also known as: Retevmo, Retsevmo

Pipeline

Phase 2: 2

Top Sponsors

  • The Netherlands Cancer Institute1
  • Massachusetts General Hospital1
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1

Indications

  • Cancer3
  • Sex Disorder1
  • Unresectable Thyroid Gland Carcinoma1
  • Metastatic Thyroid Cancer1
  • Neoplasia1

Other2 trials

ERectile Dysfunctions, gOnadotoxicity and Sexual Health Assessment in Men With Lung Cancer
The Drug Rediscovery Protocol (DRUP Trial)
Phase 2

Washington D.C., District of Columbia1 trial

Restor. I-131 Upt. + Selpercatinib in RET F-P RAI-R TC

MedStar Washington Hospital Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.